Jupiter Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-582,789
| Closed | -$67.1M | – | 444 |
|
|
2024
Q3 | $67.1M | Buy |
582,789
+275,689
| +90% | +$31.8M | 0.59% | 46 |
|
|
2024
Q2 | $42.3M | Buy |
307,100
+88,634
| +41% | +$12.2M | 0.4% | 83 |
|
|
2024
Q1 | $30.1M | Buy |
218,466
+8,375
| +4% | +$1.16M | 0.29% | 115 |
|
|
2023
Q4 | $27.7M | Buy |
210,091
+119,181
| +131% | +$15.7M | 0.27% | 107 |
|
|
2023
Q3 | $10.2M | Sell |
90,910
-236,882
| -72% | -$26.6M | 0.11% | 199 |
|
|
2023
Q2 | $30.9M | Buy |
327,792
+17,893
| +6% | +$1.69M | 0.34% | 78 |
|
|
2023
Q1 | $31.4M | Buy |
309,899
+247,248
| +395% | +$25M | 0.43% | 69 |
|
|
2022
Q4 | $7.47M | Buy |
62,651
+50,498
| +416% | +$6.02M | 0.11% | 194 |
|
|
2022
Q3 | $1.29M | Buy |
12,153
+7,094
| +140% | +$754K | 0.02% | 379 |
|
|
2022
Q2 | $493K | Buy |
+5,059
| New | +$493K | 0.01% | 489 |
|
|
2021
Q3 | – | Sell |
-37,000
| Closed | -$3.6M | – | 616 |
|
|
2021
Q2 | $3.6M | Hold |
37,000
| – | – | 0.04% | 344 |
|
|
2021
Q1 | $3.6M | Hold |
37,000
| – | – | 0.04% | 360 |
|
|
2020
Q4 | $3.55M | Hold |
37,000
| – | – | 0.04% | 363 |
|
|
2020
Q3 | $3.56M | Buy |
+37,000
| New | +$3.56M | 0.04% | 349 |
|